21:19:14 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:STAA - STAAR SURGICAL CO - https://www.staar.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
STAA - Q5.017.45·17.970.117.58+0.513.02,110.835,78417,23417.27  17.725  17.1430.81  13.5016:10:04Feb 0215 min RT 2¢

Recent Trades - Last 10 of 17234
Time ETExPriceChangeVolume
16:10:04Q17.580.511
16:10:04Q17.580.511
16:04:40Q17.580.511
16:04:33Q17.580.511
16:04:13Q17.580.511
16:04:02Q17.580.511
16:02:32Q17.580.51159
16:02:29Q17.580.51204
16:02:17Q17.580.51148
16:02:04Q17.580.51195

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-02 07:00U:STAANews ReleaseSTAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
2026-01-15 08:30U:STAANews ReleaseSTAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
2026-01-06 09:52U:STAANews ReleaseBroadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon
2026-01-06 08:47U:STAANews ReleaseSTAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
2025-12-19 12:59U:STAANews ReleaseBroadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon
2025-12-19 11:45U:STAANews ReleaseAlcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
2025-12-17 16:53U:STAANews ReleaseDefender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
2025-12-17 13:17U:STAANews ReleaseBroadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
2025-12-17 10:55U:STAANews ReleaseSTAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
2025-12-16 13:32U:STAANews ReleaseYunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory
2025-12-16 09:12U:STAANews ReleaseIndependent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
2025-12-16 07:00U:STAANews ReleaseBroadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
2025-12-15 18:35U:STAANews ReleaseLeading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger
2025-12-12 08:40U:STAANews ReleaseBroadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon
2025-12-11 09:47U:STAANews ReleaseSTAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
2025-12-11 07:00U:STAANews ReleaseBroadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
2025-12-10 07:05U:STAANews ReleaseYunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer
2025-12-09 12:39U:STAANews ReleaseBroadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical
2025-12-08 13:28U:STAANews ReleaseBroadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process
2025-12-08 08:16U:STAANews ReleaseBroadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon